Comorbidities and Disability in Multiple Sclerosis: Findings from Human Studies
A narrative review found that higher comorbidity burdens lead to longer diagnostic delays and greater disability in people with MS. Comorbidities correlated with increased disability levels and accelerated progression. The management of some comorbidities was negatively impacted by MS, and their treatment could worsen MS symptoms.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
Understanding the impact of comorbidities in MS is crucial for improving patient care and developing effective management strategies, particularly as comorbidities can complicate treatment.
What this does not prove
The review lacks rigorous evidence-based conclusions and highlights the need for further research to identify optimal treatment strategies for older adults with MS.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-06-29
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceComorbidity, Polypharmacy, and Aging in Multiple Sclerosis. ↗DOI: 10.7224/1537-2073.2025-088
Supporting passages (9)
publication date2026-06-29
findingsHigher comorbidity burden is associated with longer diagnostic delays and greater disability at diagnosis.
findingsA higher burden of comorbidities in people with MS is associated with higher disability levels and accelerated disability progression.
findingsResponses to rehabilitation therapy may also be altered in terms of timing and sustainability of response.
findingsConversely, a diagnosis of MS negatively affects the management and outcomes of some comorbidities, and treatment of certain comorbidities can worsen MS symptoms.
findingsConversely, a diagnosis of MS negatively affects the management and outcomes of some comorbidities, and treatment of certain comorbidities can worsen MS symptoms.
limitationsThis narrative review discusses how comorbid disease and polypharmacy affect people with MS, strategies to mitigate these negative risks, as well as areas where evidence is lacking and further study is needed to inform optimal treatment strategies for older adults with MS.
peer reviewedPublication types: Journal Article
subjectsA higher burden of comorbidities in people with MS is associated with higher disability levels and accelerated disability progression.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.